Healthcare -
Biotechnology - NASDAQ - US
$ 3.53
-0.843 %
$ 32.6 M
Market Cap
-0.56
P/E
SABS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss SABS - SAB Biotherapeutics, Inc.
26.4 K
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR